Antibiotic research in the age of omics: From expression profiles to interspecies communication

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 12, 2011, Pages 2689-2704

  Wecke, Tina ^a   Mascher, Thorsten ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibacterials; DNA microarray; Expression profiling; Proteomics; Transcriptomics

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZASERINE; AZITHROMYCIN; BACITRACIN; BEDAQUILINE; BERBERINE; CAPREOMYCIN; CASPOFUNGIN; CECROPIN; CEFALEXIN; CEFOTAXIME; CEFOXITIN; CEFSULODIN; CEFTAZIDIME; CERULENIN; CHLORAMPHENICOL; CHLORTETRACYCLINE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COLISTIN; COUMAMYCIN; DAPTOMYCIN; DIARYLQUINOLINE DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC BIOSYNTHESIS; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; BACTERIAL GENOME; CELL COMMUNICATION; CELLULAR STRESS RESPONSE; DRUG MECHANISM; DRUG RESEARCH; DRUG TARGETING; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE TARGETING; GENOME ANALYSIS; GENOMICS; MINIMUM INHIBITORY CONCENTRATION; MOLECULARLY TARGETED THERAPY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTION; REVIEW; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG DISCOVERY; HUMANS; PROTEOME; TRANSCRIPTOME;

EID: 81855168417     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr373     Document Type: Review

References (179)

1. Coates AR, Hu Y. Novel approaches to developing new antibiotics for bacterial infections. Br J Pharmacol 2007; 152: 1147-54.
2. Lange RP, Locher HH, Wyss PC et al. The targets of currently used antibacterial agents: lessons for drug discovery. Curr Pharm Des 2007; 13: 3140-54.
3. Pucci MJ. Novel genetic techniques and approaches in the microbial genomics era: identification and/or validation of targets for the discovery of new antibacterial agents. Drugs R D 2007; 8: 201-12.
4. Baltz RH. Renaissance in antibacterial discovery from actinomycetes. Curr Opin Pharmacol 2008; 8: 557-63.
5. Buysse JM. The role of genomics in antibacterial target discovery. Curr Med Chem 2001; 8: 1713-26.
6. Loferer H. Mining bacterial genomes for antimicrobial targets. Mol Med Today 2000; 6: 470-4.
7. Rosamond J, Allsop A. Harnessing the power of the genome in the search for new antibiotics. Science 2000; 287: 1973-6.
8. Lee DS, Burd H, Liu J et al. Comparative genome-scale metabolic reconstruction and flux balance analysis of multiple Staphylococcus aureus genomes identify novel antimicrobial drug targets. J Bacteriol 2009; 191: 4015-24.
9. Osterman AL, Begley TP. A subsystems-based approach to the identification of drug targets in bacterial pathogens. Prog Drug Res 2007; 64: 131, 133-70.
10. Raman K, Yeturu K, Chandra N. targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol 2008; 2: 109.
11. Sakharkar KR, Sakharkar MK, Chow VT. Biocomputational strategies for microbial drug target identification. Methods Mol Med 2008; 142: 1-9.
12. Thomaides HB, Davison EJ, Burston L et al. Essential bacterial functions encoded by gene pairs. J Bacteriol 2007; 189: 591-602.
13. Lerner CG, Hajduk PJ, Wagner R et al. From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzae. Chem Biol Drug Des 2007; 69: 395-404.
14. Mangat CS, Brown ED. Known bioactive small molecules probe the function of a widely conserved but enigmatic bacterial ATPase, YjeE. Chem Biol 2008; 15: 1287-95.
15. Andries K, Verhasselt P, Guillemont J et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005; 307: 223-7.
16. Pethe K, Sequeira PC, Agarwalla S et al. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat Commun 2010; 1: 57.
17. Moir DT, Ming Di, Opperman T et al. A high-throughput, homogeneous, bioluminescent assay for Pseudomonas aeruginosa gyrase inhibitors and other DNA-damaging agents. J Biomol Screen 2007; 12: 855-64.
18. Allsop AE. New antibiotic discovery, novel screens, novel targets and impact of microbial genomics. Curr Opin Microbiol 1998; 1: 530-4.
19. Gross H. Genomic mining-a concept for the discovery of new bioactive natural products. Curr Opin Drug Discov Devel 2009; 12: 207-19.
20. Nes IF, Johnsborg O. Exploration of antimicrobial potential in LAB by genomics. Curr Opin Biotechnol 2004; 15: 100-4.
21. Li M, Ung P, Zajkowski J et al. Automated genome mining for natural products. BMC Bioinformatics 2009; 10: 185.
22. Starcevic A, Zucko J, Simunkovic J et al. ClustScan: an integrated program package for the semi-automatic annotation of modular biosynthetic gene clusters and in silico prediction of novel chemical structures. Nucleic Acids Res 2008; 36: 6882-92.
23. Weber T, Rausch C, Lopez P et al. CLUSEAN: a computer-based framework for the automated analysis of bacterial secondary metabolite biosynthetic gene clusters. J Biotechnol 2009; 140: 13-7.
24. de Bruijn I, de Kock MJ, Yang M et al. Genome-based discovery, structure prediction and functional analysis of cyclic lipopeptide antibiotics in Pseudomonas species. Mol Microbiol 2007; 63: 417-28.
25. Koumoutsi A, Chen XH, Henne A et al. Structural and functional characterization of gene clusters directing nonribosomal synthesis of bioactive cyclic lipopeptides in Bacillus amyloliquefaciens strain FZB42. J Bacteriol 2004; 186: 1084-96.
26. Chen X-H, Vater J, Piel J et al. Structural and functional characterization of three polyketide synthase gene clusters in Bacillus amyloliquefaciens FZB 42. J Bacteriol 2006; 188: 4024-36.
27. Choi SK, Park SY, Kim R et al. Identification of a polymyxin synthetase gene cluster of Paenibacillus polymyxa and heterologous expression of the gene in Bacillus subtilis. J Bacteriol 2009; 191: 3350-8.
28. Corre C, Song L, O'Rourke S et al. 2-Alkyl-4-hydroxymethylfuran-3-carboxylic acids, antibiotic production inducers discovered by Streptomyces coelicolor genome mining. Proc Natl Acad Sci USA 2008; 105: 17510-5.
29. Bode HB, Bethe B, Höfs R et al. Big effects from small changes: possible ways to explore nature's chemical diversity. Chembiochem 2002; 3: 619-27.
30. Hosaka T, Ohnishi-Kameyama M, Muramatsu H et al. Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12. Nat Biotech 2009; 27: 462-4.
31. Medema MH, Breitling R, Bovenberg R et al. Exploiting plug-and-play synthetic biology for drug discovery and production in microorganisms. Nat Rev Microbiol 2011; 9: 131-7.
32. Menzella HG, Carney JR, Santi DV. Rational design and assembly of synthetic trimodular polyketide synthases. Chem Biol 2007; 14: 143-51.
33. Wilson M, DeRisi J, Kristensen HH et al. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci USA 1999; 96: 12833-8.
34. Bandow JE, Hecker M. Proteomic profiling of cellular stresses in Bacillus subtilis reveals cellular networks and assists in elucidating antibiotic mechanisms of action. Prog Drug Res 2007; 64: 79, 81-101.
35. Brotz-Oesterhelt H, Bandow JE, Labischinski H. Bacterial proteomics and its role in antibacterial drug discovery. Mass Spectrom Rev 2005; 24: 549-65.
36. Wenzel M, Bandow JE. Proteomic signatures in antibiotic research. Proteomics 2011; 11: 3256-68.
37. Jordan S, Hutchings MI, Mascher T. Cell envelope stress response in Gram-positive bacteria. FEMS Microbiol Rev 2008; 32: 107-46.
38. Cao M, Wang T, Ye R et al. Antibiotics that inhibit cell wall biosynthesis induce expression of the Bacillus subtilis sW and sM regulons. Mol Microbiol 2002; 45: 1267-76.
39. Mascher T, Margulis NG, Wang T et al. Cell wall stress responses in Bacillus subtilis: the regulatory network of the bacitracin stimulon. Mol Microbiol 2003; 50: 1591-604.
40. Pietiäinen M, Gardemeister M, Mecklin M et al. Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems. Microbiology 2005; 151: 1577-92.
41. Wecke T, Veith B, Ehrenreich A et al. Cell envelope stress response in Bacillus licheniformis: integrating comparative genomics, transcriptional profiling, and regulon mining to decipher a complex regulatory network. J Bacteriol 2006; 188: 7500-11.
42. Kuroda M, Kuroda H, Oshima T et al. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 2003; 49: 807-21.
43. Kuroda M, Kuwahara-Arai K, Hiramatsu K. Identification of the upand down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. Biochem Biophys Res Commun 2000; 269: 485-90.
44. McAleese F, Wu SW, Sieradzki K et al. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate S. aureus-type resistance to vancomycin. J Bacteriol 2006; 188: 1120-33.
45. McCallum N, Spehar G, Bischoff M et al. Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureus. Biochim Biophys Acta 2006; 1760: 1475-81.
46. Utaida S, Dunman PM, Macapagal D et al. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 2003; 149: 2719-32.
47. Wang X, He X, Jiang Z et al. Proteomic analysis of the Enterococcus faecalis V583 strain and clinical isolate V309 under vancomycin treatment. J Proteome Res 2010; 9: 1772-85.
48. Sharma P, Kumar B, Gupta Y et al. Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis. Proteome Sci 2010; 8: 59.
49. Hachmann A-B, Angert ER, Helmann JD. Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin. Antimicrob Agents Chemother 2009; 53: 1598-609.
50. Lai Y, Villaruz AE, Li M et al. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol Microbiol 2007; 63: 497-506.
51. Colangeli R, Helb D, Vilcheze C et al. Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis. PLoS Pathog 2007; 3: e87.
52. Brazas MD, Hancock RE. Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005; 49: 3222-7.
53. Marrer E, Satoh AT, Johnson MM et al. Global transcriptome analysis of the responses of a fluoroquinolone-resistant Streptococcus pneumoniae mutant and its parent to ciprofloxacin. Antimicrob Agents Chemother 2006; 50: 269-78.
54. Boshoff HIM, Myers TG, Copp BR et al. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J Biol Chem 2004; 279: 40174-84.
55. Hutter B, Schaab C, Albrecht S et al. Prediction of mechanisms of action of antibacterial compounds by gene expression profiling. Antimicrob Agents Chemother 2004; 48: 2838-44.
56. Bandow JE, Brotz H, Leichert LI et al. Proteomic approach to understanding antibiotic action. Antimicrob Agents Chemother 2003; 47: 948-55.
57. Hutter B, Fischer C, Jacobi A et al. Panel of Bacillus subtilis reporter strains indicative of various modes of action. Antimicrob Agents Chemother 2004; 48: 2588-94.
58. Urban A, Eckermann S, Fast B et al. Novel whole-cell antibiotic biosensors for compound discovery. Appl Environ Microbiol 2007; 73: 6436-43.
59. Mariner KR, Ooi N, Roebuck D et al. Further characterization of Bacillus subtilis antibiotic biosensors and their use for antibacterial mode-of-action studies. Antimicrob Agents Chemother 2011; 55: 1784-6.
60. Nanduri B, Shack LA, Burgess SC et al. The transcriptional response of Pasteurella multocida to three classes of antibiotics. BMC Genomics 2009;10: Suppl 2: S4.
61. Wang R, Marcotte EM. The proteomic response of Mycobacterium smegmatis to anti-tuberculosis drugs suggests targeted pathways. J Proteome Res 2008; 7: 855-65.
62. Wecke T, Zühlke D, Mäder U et al. Daptomycin versus friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responses. Antimicrob Agents Chemother 2009; 53: 1619-23.
63. Raafat D, von Bargen K, Haas A et al. Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol 2008; 74: 3764-73.
64. Schneider T, Gries K, Josten M et al. The lipopeptide antibiotic friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob Agents Chemother 2009; 53: 1610-8.
65. Schneider T, Kruse T, Wimmer R et al. Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II. Science 2010; 328: 1168-72.
66. Shin J-H, Kim J, Kim S-M et al. sB-dependent protein induction in Listeria monocytogenes during vancomycin stress. FEMS Microbiol Lett 2010; 308: 94-100.
67. Dwyer DJ, Kohanski MA, Hayete B et al. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol 2007; 3: 91.
68. O'Sullivan DM, Hinds J, Butcher PD et al. Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin. J Antimicrob Chemother 2008; 62: 1199-202.
69. Phillips I, Culebras E, Moreno F et al. Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother 1987; 20: 631-8.
70. Coates ARM, Halls G, Hu Y. Novel classes of antibiotics or more of the same? Br J Pharmacol 2011; 163: 184-94.
71. Kohanski MA, Dwyer DJ, Hayete B et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130: 797-810.
72. Bushby SR, Hitchings GH. Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother 1968; 33: 72-90.
73. Reeves DS. Sulphamethoxazole/trimethoprim: the first two years. J Clin Pathol 1971; 24: 430-7.
74. Lamb HM, Figgitt DP, Faulds D. Quinupristin/dalfopristin: a review of its use in the management of serious Gram-positive infections. Drugs 1999; 58: 1061-97.
75. Livermore DM. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use? J Antimicrob Chemother 2000; 46: 347-50.
76. Nadler H, Dowzicky MJ, Feger C et al. Quinupristin/dalfopristin: a novel selective-spectrum antibiotic for the treatment of multi-resistant and other gram-positive infections. Clin Mic News 1999; 21: 103-12.
77. Howard BM, Pinney RJ, Smith JT. Function of the SOS process in repair of DNA damage induced by modern 4-quinolones. J Pharm Pharmacol 1993; 45: 658-62.
78. Plotz PH, Davis BD. Synergism between streptomycin and penicillin: a proposed mechanism. Science 1962; 135: 1067-8.
79. Buynak JD. Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinations. Biochem Pharmacol 2006; 71: 930-40.
80. Bush K. β-Lactamase inhibitors from laboratory to clinic. Clin Microbiol Rev 1988; 1: 109-23.
81. Drawz SM, Bonomo RA. Three decades of β-lactamase inhibitors. Clin Microbiol Rev 2010; 23: 160-201.
82. Davies J, Spiegelman GB, Yim G. The world of subinhibitory antibiotic concentrations. Curr Opin Microbiol 2006; 9: 445-53.
83. Goh EB, Yim G, Tsui W et al. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc Natl Acad Sci USA 2002; 99: 17025-30.
84. Hoffman LR, D'Argenio DA, MacCoss MJ et al. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005; 436: 1171-5.
85. Linares JF, Gustafsson I, Baquero F et al. Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci USA 2006; 103: 19484-9.
86. Fogaça AC, Zaini PA, Wulff NA et al. Effects of the antimicrobial peptide gomesin on the global gene expression profile, virulence and biofilm formation of Xylella fastidiosa. FEMS Microbiol Lett 2010; 306: 152-9.
87. Mah T-FC, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34-9.
88. Stein T. Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol Microbiol 2005; 56: 845-57.
89. Nes IF, Diep DB, Holo H. Bacteriocin diversity in Streptococcus and Enterococcus. J Bacteriol 2007; 189: 1189-98.
90. Severinov K, Semenova E, Kazakov A et al. Low-molecular-weight post-translationally modified microcins. Mol Microbiol 2007; 65: 1380-94.
91. Cotter PD, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 2005; 3: 777-88.
92. Kleerebezem M. Quorum sensing control of lantibiotic production; nisin and subtilin autoregulate their own biosynthesis. Peptides 2004; 25: 1405-14.
93. Williams P, Winzer K, Chan WC et al. Look who's talking: communication and quorum sensing in the bacterial world. Philos Trans R Soc B Biol Sci 2007; 362: 1119-34.
94. Hamoen LW, Venema G, Kuipers OP. Controlling competence in Bacillus subtilis: shared use of regulators. Microbiology 2003; 149: 9-17.
95. Babic F, Venturi V, Maravic-Vlahovicek G. Tobramycin at subinhibitory concentration inhibits the RhlI/R quorum sensing system in a Pseudomonas aeruginosa environmental isolate. BMC Infect Dis 2010; 10: 148.
96. Kaufmann GF, Sartorio R, Lee S-H et al. Revisiting quorum sensing: discovery of additional chemical and biological functions for 3-oxo-N-acylhomoserine lactones. Proc Natl Acad Sci USA 2005; 102: 309-14.
97. Livermore DM. Discovery research: the scientific challenge of finding new antibiotics. J Antimicrob Chemother 2011; 66: 1941-4.
98. Bush K, Pucci MJ. New antimicrobial agents on the horizon. Biochem Pharmacol 2011; doi:10.1016/j.bcp.2011.07.077.
99. Payne DJ, Gwynn MN, Holmes DJ et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007; 6: 29-40.
100. Projan SJ. Why is big pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 2003; 6: 427-30.
101. Bhatnagar I, Kim S-K. Immense essence of excellence: marine microbial bioactive compounds. Mar Drugs 2010; 8: 2673-701.
102. Daniel R. The soil metagenome-a rich resource for the discovery of novel natural products. Curr Opin Biotechnol 2004; 15: 199-204.
103. D'Costa VM, McGrann KM, Hughes DW et al. Sampling the antibiotic resistome. Science 2006; 311: 374-7.
104. Rondon MR, August PR, Bettermann AD et al. Cloning the soil metagenome: a strategy for accessing the genetic and functional diversity of uncultured microorganisms. Appl Environ Microbiol 2000; 66: 2541-7.
105. Gillespie DE, Brady SF, Bettermann AD et al. Isolation of antibiotics turbomycin A and B from a metagenomic library of soil microbial DNA. Appl Environ Microbiol 2002; 68: 4301-6.
106. Freiberg C, Fischer HP, Brunner NA. Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants. Antimicrob Agents Chemother 2005; 49: 749-59.
107. Rukmana A, Morimoto T, Takahashi H et al. Assessment of transcriptional responses of Bacillus subtilis cells to the antibiotic enduracidin, which interferes with cell wall synthesis, using a high-density tiling chip. Genes Genet Syst 2009; 84: 253-67.
108. Hansen ME, Wangari R, Hansen EB et al. Engineering of Bacillus subtilis 168 for increased nisin resistance. Appl Env Microbiol 2009; 75: 6688-95.
109. Salzberg LI, Luo Y, Hachmann AB et al. The Bacillus subtilis GntR family repressor YtrA responds to cell wall antibiotics. J Bacteriol 2011; doi:10.1128/JB.05862-11.
110. Emerson JE, Stabler RA, Wren BW et al. Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress. J Med Microbiol 2008; 57: 757-64.
111. Shaw KJ, Miller N, Liu X et al. Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents. J Mol Microbiol Biotechnol 2003; 5: 105-22.
112. Kaldalu N, Mei R, Lewis K. Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile. Antimicrob Agents Chemother 2004; 48: 890-6.
113. Laubacher ME, Ades SE. The Rcs phosphorelay is a cell envelope stress response activated by peptidoglycan stress and contributes to intrinsic antibiotic resistance. J Bacteriol 2008; 190: 2065-74.
114. Martinez B, Zomer AL, Rodriguez A et al. Cell envelope stress induced by the bacteriocin Lcn972 is sensed by the lactococcal two-component system CesSR. Mol Microbiol 2007; 64: 473-86.
115. Radmacher E, Stansen KC, Besra GS et al. Ethambutol, a cell wall inhibitor of Mycobacterium tuberculosis, elicits L-glutamate efflux of Corynebacterium glutamicum. Microbiology 2005; 151: 1359-68.
116. Provvedi R, Boldrin F, Falciani F et al. Global transcriptional response to vancomycin in Mycobacterium tuberculosis. Microbiology 2009; 155: 1093-102.
117. Bagge N, Schuster M, Hentzer M et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and β-lactamase and alginate production. Antimicrob Agents Chemother 2004; 48: 1175-87.
118. Skindersoe ME, Alhede M, Phipps R et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008; 52: 3648-63.
119. Kuroda H, Kuroda M, Cui L et al. Subinhibitory concentrations of β-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system. FEMS Microbiol Lett 2007; 268: 98-105.
120. Muthaiyan A, Silverman JA, Jayaswal RK et al. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob Agents Chemother 2008; 52: 980-90.
121. O'Neill AJ, Lindsay JA, Gould K et al. Transcriptional signature following inhibition of early-stage cell wall biosynthesis in Staphylococcus aureus. Antimicrob Agents Chemother 2009; 53: 1701-4.
122. Sass P, Jansen A, Szekat C et al. The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus. BMC Microbiol 2008; 8: 186.
123. Petek M, Baebler S, Kuzman D et al. Revealing fosfomycin primary effect on Staphylococcus aureus transcriptome: modulation of cell envelope biosynthesis and phosphoenolpyruvate induced starvation. BMC Microbiol 2010; 10: 159.
124. Haas W, Kaushal D, Sublett J et al. Vancomycin stress response in a sensitive and a tolerant strain of Streptococcus pneumoniae. J Bacteriol 2005; 187: 8205-10.
125. Rogers PD, Liu TT, Barker KS et al. Gene expression profiling of the response of Streptococcus pneumoniae to penicillin. J Antimicrob Chemother 2007; 59: 616-26.
126. Agarwal AK, Rogers PD, Baerson SR et al. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J Biol Chem 2003; 278: 34998-5015.
127. Liu TT, Lee RE, Barker KS et al. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 2005; 49: 2226-36.
128. Harris DM, van der Krogt ZA, Klaassen P et al. Exploring and dissecting genome-wide gene expression responses of Penicillium chrysogenum to phenylacetic acid consumption and penicillinG production. BMC Genomics 2009; 10: 75.
129. Majchrzykiewicz JA, Kuipers OP, Bijlsma JJE. Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin. Antimicrob Agents Chemother 2010; 54: 440-51.
130. Sender U, Bandow J, Engelmann S et al. Proteomic signatures for daunomycin and adriamycin in Bacillus subtilis. Pharmazie 2004; 59: 65-70.
131. Herold S, Siebert J, Huber A et al. Global expression of prophage genes in Escherichia coli O157:H7 strain EDL933 in response to norfloxacin. Antimicrob Agents Chemother 2005; 49: 931-44.
132. Oppegard LM, Hamann BL, Streck KR et al. In vivo and in vitro patterns of the activity of simocyclinone D8, an angucyclinone antibiotic from Streptomyces antibioticus. Antimicrob Agents Chemother 2009; 53: 2110-9.
133. Coldham NG, Randall LP, Piddock LJ et al. Effect of fluoroquinolone exposure on the proteome of Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2006; 58: 1145-53.
134. Doyle M, Feuerbaum E-A, Fox KR et al. Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer. J Antimicrob Chemother 2009; 64: 949-59.
135. Wenzel M, Patra M, Albrecht D et al. Proteomic signature of fatty acid biosynthesis inhibition available for in vivo mechanism-of-action studies. Antimicrob Agents Chemother 2011; 55: 2590-6.
136. Hughes MA, Silva JC, Geromanos SJ et al. Quantitative proteomic analysis of drug-induced changes in mycobacteria. J Proteome Res 2006; 5: 54-63.
137. Betts JC, McLaren A, Lennon MG et al. Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47: 2903-13.
138. Waddell SJ, Stabler RA, Laing K et al. The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinb) 2004; 84: 263-74.
139. Fu LM. Exploring drug action on Mycobacterium tuberculosis using affymetrix oligonucleotide genechips. Tuberculosis (Edinb) 2006; 86: 134-43.
140. Jang HJ, Chang MW, Toghrol F et al. Microarray analysis of toxicogenomic effects of triclosan on Staphylococcus aureus. Appl Microbiol Biotechnol 2008; 78: 695-707.
141. Webber MA, Coldham NG, Woodward MJ et al. Proteomic analysis of triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2008; 62: 92-7.
142. Wecke T, Bauer T, Harth H et al. The rhamnolipid stress response of Bacillus subtilis. FEMS Microbiol Lett 2011: doi:10.1111/j.1574-6968.2011.02367.x.
143. Hong RW, Shchepetov M, Weiser JN et al. Transcriptional profile of the Escherichia coli response to the antimicrobial insect peptide cecropin A. Antimicrob Agents Chemother 2003; 47: 1-6.
144. Marcellini L, Borro M, Gentile G et al. Esculentin-1b(1-18)-a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli. FEBS J 2009; 276: 5647-64.
145. Pietiäinen M, Francois P, Hyyryläinen H-L et al. Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 2009; 10: 429.
146. Bader MW, Navarre WW, Shiau W et al. Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol 2003; 50: 219-30.
147. Gautam P, Shankar J, Madan T et al. Proteomic and transcriptomic analysis of Aspergillus fumigatus on exposure to amphotericin B. Antimicrob Agents Chemother 2008; 52: 4220-7.
148. Zhang L, Zhang Y, Zhou Y et al. Response of gene expression in Saccharomyces cerevisiae to amphotericin B and nystatin measured by microarrays. J Antimicrob Chemother 2002; 49: 905-15.
149. Yu L, Zhang W, Wang L et al. Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum. Antimicrob Agents Chemother 2007; 51: 144-53.
150. Grande Burgos M, Kovacs A, Mironczuk A et al. Response of Bacillus cereus ATCC 14579 to challenges with sublethal concentrations of enterocin AS-48. BMC Microbiol 2009; 9: 227.
151. Yun S-H, Choi C-W, Park S-H et al. Proteomic analysis of outer membrane proteins from Acinetobacter baumannii DU202 in tetracycline stress condition. J Microbiol 2008; 46: 720-7.
152. Yun S-H, Choi C-W, Kwon S-O et al. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii. J Proteome Res 2010; 10: 459-69.
153. Lin JT, Connelly MB, Amolo C et al. Global transcriptional response of Bacillus subtilis to treatment with subinhibitory concentrations of antibiotics that inhibit protein synthesis. Antimicrob Agents Chemother 2005; 49: 1915-26.
154. Aakra A, Vebo H, Snipen L et al. Transcriptional response of Enterococcus faecalis V583 to erythromycin. Antimicrob Agents Chemother 2005; 49: 2246-59.
155. Evers S, Di Padova K, Meyer M et al. Mechanism-related changes in the gene transcription and protein synthesis patterns of Haemophilus influenzae after treatment with transcriptional and translational inhibitors. Proteomics 2001; 1: 522-44.
156. Lin X-M, Yang J-N, Peng X-X et al. A novel negative regulation mechanism of bacterial outer membrane proteins in response to antibiotic resistance. J Proteome Res 2010; 9: 5952-9.
157. Fu LM, Shinnick TM. Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips. J Infect 2007; 54: 277-84.
158. Sharma P, Kumar B, Singhal N et al. Streptomycin induced protein expression analysis in Mycobacterium tuberculosis by two-dimensional gel electrophoresis & mass spectrometry. Indian J Med Res 2010; 132: 400-8.
159. Kai T, Tateda K, Kimura S et al. A low concentration of azithromycin inhibits the mRNA expression of N-acyl homoserine lactone synthesis enzymes, upstream of lasI or rhlI, in Pseudomonas aeruginosa. Pulm Pharmacol Ther 2009; 22: 483-6.
160. Cummins J, Reen FJ, Baysse C et al. Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in Pseudomonas aeruginosa. Microbiology 2009; 155: 2826-37.
161. Delgado A, Zaman S, Muthaiyan A et al. The fusidic acid stimulon of Staphylococcus aureus. J Antimicrob Chemother 2008; 62: 1207-14.
162. Smith K, Gould KA, Ramage G et al. Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010; 54: 380-7.
163. Ng WL, Kazmierczak KM, Robertson GT et al. Transcriptional regulation and signature patterns revealed by microarray analyses of Streptococcus pneumoniae R6 challenged with sublethal concentrations of translation inhibitors. J Bacteriol 2003; 185: 359-70.
164. Montero CI, Johnson MR, Chou CJ et al. Responses of wild-type and resistant strains of the hyperthermophilic bacterium Thermotoga maritima to chloramphenicol challenge. Appl Environ Microbiol 2007; 73: 5058-65.
165. Qiu J, Zhou D, Han Y et al. Global gene expression profile of Yersinia pestis induced by streptomycin. FEMS Microbiol Lett 2005; 243: 489-96.
166. Qiu J, Zhou D, Qin L et al. Microarray expression profiling of Yersinia pestis in response to chloramphenicol. FEMS Microbiol Lett 2006; 263: 26-31.
167. Dahl EL, Shock JL, Shenai BR et al. Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 2006; 50: 3124-31.
168. Van La M, Barbry P, Raoult D et al. Molecular basis of Tropheryma whipplei doxycycline susceptibility examined by transcriptional profiling. J Antimicrob Chemother 2007; 59: 370-7.
169. Ren D, Bedzyk LA, Setlow P et al. Differential gene expression to investigate the effect of (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone on Bacillus subtilis. Appl Environ Microbiol 2004; 70: 4941-9.
170. Tomasinsig L, Scocchi M, Mettulio R et al. Genome-wide transcriptional profiling of the Escherichia coli response to a proline-rich antimicrobial peptide. Antimicrob Agents Chemother 2004; 48: 3260-7.
171. Cho YS, Schiller NL, Kahng HY et al. Cellular responses and proteomic analysis of Escherichia coli exposed to green tea polyphenols. Curr Microbiol 2007; 55: 501-6.
172. Wang D, Yu L, Xiang H et al. Global transcriptional profiles of Staphylococcus aureus treated with berberine chloride. FEMS Microbiol Lett 2008; 279: 217-25.
173. Sass V, Pag U, Tossi A et al. Mode of action of human b-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. Int J Med Microbiol 2008; 298: 619-33.
174. Feng H, Xiang H, Zhang J et al. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cryptotanshinone. J Biomed Biotechnol 2009; 2009: 617509.
175. Sianglum W, Srimanote P, Wonglumsom Wet al. Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate. PLoS ONE 2011; 6: e16628.
176. Janssens JC, Steenackers H, Robijns S et al. Brominated furanones inhibit biofilm formation by Salmonella enterica serovar Typhimurium. Appl Environ Microbiol 2008; 74: 6639-48.
177. Plowright AT, Schaus SE, Myers AG. Transcriptional response pathways in a yeast strain sensitive to saframycin a and a more potent analog: evidence for a common basis of activity. Chem Biol 2002; 9: 607-18.
178. Fu H, Liu L-G, Peng J-P et al. Transcriptional profile of the Shigella flexneri response to an alkaloid: berberine. FEMS Microbiol Lett 2010; 303: 169-75.
179. de Hoon MJL, Imoto S, Nolan J et al. Open source clustering software. Bioinformatics 2004; 20: 1453-4.